Kim Hyong 4
Research Summary
AI-generated summary
Alignment Healthcare (ALHC) CMO Hyong Receives 52,972 RSUs
What Happened Kim Hyong, Chief Medical Officer of Alignment Healthcare, received a grant of 52,972 restricted stock units (RSUs) on March 13, 2026. The Form 4 records the acquisition as an award (code A) at $0.00 per unit (total dollar amount not reported on the form). This is a compensation/retention grant rather than a market purchase or sale.
Key Details
- Transaction date: 2026-03-13; reported on Form 4 filed 2026-03-17 (filed within the standard two business-day window).
- Instrument and amount: 52,972 restricted stock units (RSUs) — reported as 52,972 shares @ $0.00.
- Vesting: Per the filing footnote, the RSUs vest approximately one-third on each of the first three anniversaries of the grant date, subject to continued service.
- Shares owned after transaction: Not specified in the provided filing excerpt.
- No 10b5-1 plan, tax-withholding sale, or other special instructions were indicated in the excerpt.
Context RSU grants are common executive compensation/retention tools; they convert into actual shares only as they vest, so this award does not represent immediate market buying or selling. For investors, such grants are routine and intended to align executive incentives with shareholder value over time rather than signal near-term insider conviction.